INS and metabolic dysfunction-associated steatohepatitis: Here, we demonstrate the protective role of insulin signaling in the gut against hepatocarcinogenesis associated with maintaining intestinal barrier function and suppressing dysbiosis using diabetic NASH-HCC model mice and samples from patients with diabetes and NASH.